Jefferies Financial Group Inc. Buys 14,393 Shares of Stryker Corporation $SYK

Jefferies Financial Group Inc. lifted its holdings in Stryker Corporation (NYSE:SYK) by 225.9% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 20,765 shares of the medical technology company’s stock after purchasing an additional 14,393 shares during the period. Jefferies Financial Group Inc.’s holdings in Stryker were worth $7,298,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Czech National Bank increased its holdings in Stryker by 3.9% in the 4th quarter. Czech National Bank now owns 90,755 shares of the medical technology company’s stock worth $31,898,000 after acquiring an additional 3,366 shares in the last quarter. Davis R M Inc. grew its holdings in Stryker by 1.8% during the 3rd quarter. Davis R M Inc. now owns 138,732 shares of the medical technology company’s stock valued at $51,285,000 after buying an additional 2,512 shares in the last quarter. Terra Alpha Investments LLC purchased a new stake in Stryker during the 3rd quarter valued at approximately $1,216,000. Kepler Cheuvreux Suisse SA purchased a new stake in Stryker during the 3rd quarter valued at approximately $27,952,000. Finally, Daymark Wealth Partners LLC grew its holdings in Stryker by 436.0% during the 4th quarter. Daymark Wealth Partners LLC now owns 45,863 shares of the medical technology company’s stock valued at $16,119,000 after buying an additional 37,307 shares in the last quarter. Institutional investors own 77.09% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on SYK. Citigroup cut their target price on shares of Stryker from $420.00 to $385.00 and set a “buy” rating for the company in a report on Tuesday, April 7th. Evercore set a $355.00 target price on Stryker in a research report on Friday, May 1st. Weiss Ratings downgraded Stryker from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, May 4th. Robert W. Baird set a $385.00 price target on Stryker in a research note on Friday, May 1st. Finally, Wells Fargo & Company cut their price target on Stryker from $456.00 to $418.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Sixteen analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $395.48.

Stryker Trading Down 0.0%

Shares of NYSE:SYK opened at $316.39 on Tuesday. Stryker Corporation has a 12-month low of $281.00 and a 12-month high of $404.87. The company has a market capitalization of $121.29 billion, a PE ratio of 36.62, a PEG ratio of 1.99 and a beta of 0.80. The business has a 50 day moving average of $324.80 and a two-hundred day moving average of $349.43. The company has a current ratio of 2.11, a quick ratio of 1.25 and a debt-to-equity ratio of 0.62.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The company had revenue of $6.02 billion during the quarter, compared to analyst estimates of $6.34 billion. Stryker had a net margin of 13.20% and a return on equity of 23.42%. The company’s revenue was up 2.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, analysts forecast that Stryker Corporation will post 14.98 EPS for the current year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be paid a $0.88 dividend. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Tuesday, June 30th. Stryker’s dividend payout ratio is currently 40.74%.

Insider Buying and Selling

In other Stryker news, VP M Kathryn Fink sold 5,220 shares of the company’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $283.85, for a total value of $1,481,697.00. Following the completion of the sale, the vice president directly owned 13,137 shares in the company, valued at $3,728,937.45. This represents a 28.44% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 4.60% of the company’s stock.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.